×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RNAC – cartesian therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RNAC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
07:11 am
rnac
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit [Yahoo! Finance]
Medium
Report
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit [Yahoo! Finance]
11/21
07:00 am
rnac
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit
Medium
Report
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit
11/21
05:35 am
rnac
Timothy Springer Bought 4.9% More Shares In Cartesian Therapeutics [Yahoo! Finance]
Low
Report
Timothy Springer Bought 4.9% More Shares In Cartesian Therapeutics [Yahoo! Finance]
11/14
10:14 am
rnac
Yale University's Strategic Bet on Cartesian Therapeutics Skyrockets in Q3 2024 [Yahoo! Finance]
Medium
Report
Yale University's Strategic Bet on Cartesian Therapeutics Skyrockets in Q3 2024 [Yahoo! Finance]
11/8
02:32 pm
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its price target lowered by analysts at HC Wainwright from $45.00 to $41.00. They now have a "buy" rating on the stock.
Low
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its price target lowered by analysts at HC Wainwright from $45.00 to $41.00. They now have a "buy" rating on the stock.
11/8
08:46 am
rnac
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
Low
Report
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $41.00 price target on the stock.
11/8
07:05 am
rnac
Cartesian Therapeutics Announces New Employment Inducement Grants
Medium
Report
Cartesian Therapeutics Announces New Employment Inducement Grants
11/7
10:36 am
rnac
Cartesian Therapeutics, Inc. (RNAC) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
Low
Report
Cartesian Therapeutics, Inc. (RNAC) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
5/8/2024
07:00 am
rnac
cartesian therapeutics, inc.
MISS
Report
1.1%
cartesian therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
04:58 pm
rnac
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Low
Report
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
11/19
04:37 pm
rnac
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Medium
Report
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
11/18
09:45 pm
rnac
Form SC 13D/A Cartesian Therapeutics, Filed by: SPRINGER TIMOTHY A
Medium
Report
Form SC 13D/A Cartesian Therapeutics, Filed by: SPRINGER TIMOTHY A
11/18
07:36 pm
rnac
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: SPRINGER TIMOTHY A
Medium
Report
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: SPRINGER TIMOTHY A
11/18
07:33 pm
rnac
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: Kurtoglu Metin
Medium
Report
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: Kurtoglu Metin
11/18
07:28 pm
rnac
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: Miljkovic Milos
Medium
Report
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: Miljkovic Milos
11/18
07:24 pm
rnac
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: Jewell Christopher M
Medium
Report
Form 4 Cartesian Therapeutics, For: Nov 14 Filed by: Jewell Christopher M
11/18
04:25 pm
rnac
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Medium
Report
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: